A Potent Alternative to Clopidogrel Emerges

Prasugrel appears to lower heart attack risk for patients with acute coronary syndrome.

Clopidogrel (Plavix) is one of the best-selling drugs in the world and is a proven treatment to help reduce the risk of blood clot formation in patients with coronary artery disease, peripheral vascular disease and cerebrovascular disease. However, about 25 percent of the patients who are prescribed clopidogrel dont respond well to it, explains Stephen G. Ellis, MD, Section Head of Invasive/Interventional Cardiology in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access